Data coverage, completeness and provenance for NYRADA INC. in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T05:10:11. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.4600 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.4900 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.4950 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.4850 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.4750 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/NYR/prices · Price parameters and adjustment semantics
Nyrada Inc., a clinical-stage biotechnology company, focuses on the discovery and development of small-molecule therapies for neuroprotection and cardioprotection indications in Australasia. Its lead candidate is Xolatryp, a small-molecule inhibitor targeting the transient receptor potential canonical ion channel subtypes 3, 6, and 7, which is in a Phase IIa clinical trial to treat myocardial ischemia, arrhythmia, stroke, and traumatic brain injury, as well as in a preclinical research stage for oncology indications. Nyrada Inc. was incorporated in 2017 and is based in Sydney, Australia.
Website: https://www.nyrada.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/NYR/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 22 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 23 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 23 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 21 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 6 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/NYR
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/NYR/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/NYR/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/NYR/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/NYR/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/NYR
Free tier — instant API key. Built for AI agents.